• 28.03.2007, 14:42:37
  • /
  • OTE0008

euro adhoc: november AG / Personnel / New executive board will be assigned on 01.04.2007 Supervisory board appoints Dr. Müller as chief executive officer, Mr. Schüren and Ms. Dickert agreed to resign amicably from their offices. (E)

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

28.03.2007

Erlangen, 28 March 2007. On today’s scheduled supervisory board-meeting of
november AG, a biotech development and investment holding in Erlangen, Germany
(ISIN DE0006762909) Mr Reinhard Schüren as CEO and Ms. Astrid Dickert as CFO,
announced that they have amicably agreed upon their resignation with the
supervisory board effective 31st March 2007. The supervisory board unanimously
appointed Dr. Claus Müller effective 01.04.2007 as new CEO until 31.03.2010. Dr.
Müller will also be responsible for the new executive department "Sales &
Marketing". As further members of the company’s executive board, the supervisory
board appointed Mr. Jürgen Haegele as CFO until 30.09.2007 and Prof. Dr. Dr.
Hans Alois Dresel (research & development) until 31.03.2010, both effective
01.04.2007.

Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: [email protected]

end of announcement euro adhoc 28.03.2007 14:07:47
--------------------------------------------------------------------------------

emitter: november AG
Ulrich-Schalk-Str. 3a
D-91056 Erlangen
phone: +49(0)9131-75088-0
FAX: +49(0)9131-75088-99
mail: [email protected]
WWW: http://www.november.de
ISIN: DE0006762909
indexes: CDAX, Technologie All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurter Wertpapierbörse,
free trade: Börse Berlin-Bremen, Baden-Württembergische
Wertpapierbörse, Börse Düsseldorf, Niedersächsische Börse zu
Hannover, Bayerische Börse
sector: Biotechnology
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | OTB

Bei Facebook teilen.
Bei X teilen.
Bei LinkedIn teilen.
Bei Xing teilen.
Bei Bluesky teilen

Stichworte

Channel